SCHEMBL8781095

SCHEMBL8781095

CCCC(N)c1ccccc1OCc1ccncc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 2/20 0.46
▸ AOC3 Q16853 1/20 0.40
▸ LTA4H P09960 1/20 0.40
▸ MAPK14 Q16539 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ SGMS2 Q8NHU3 2/20 0.39
▸ IKBKB O14920 1/20 0.38
▸ MAPT P10636 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ NISCH Q9Y2I1 2/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ ADRA1D P25100 1/20 0.37
▸ ADRA1A P35348 1/20 0.37
▸ ADRA1B P35368 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8781042 0.85 DRD2 (0.50) AOC3LTA4HMAPK14ALDH1A1LMNA
SCHEMBL8781006 0.81 SYK (0.47) ABCB1HTR1A
SCHEMBL2652374 0.80 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2MAPTMAPK1TDP1
SCHEMBL18430835 0.79 NISCH (0.55) ABCB1LTA4HMAPK14ALDH1A1LMNA
SCHEMBL9460724 0.76 HTR1A (0.53) AOC3LTA4HMAPK14ALDH1A1LMNA
Hydrochloric Acid SCHEMBL9461010 0.75 HTR1A (0.51) AOC3LTA4HMAPK14ALDH1A1LMNA
SCHEMBL8781026 0.72 CYP1A2 (0.47) ABCB1HTR1A
SCHEMBL14614608 0.71 ABCB1 (0.67) ABCB1ALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL8780987 0.71 CYP1A2 (0.47) ABCB1HTR1A
SCHEMBL3680376 0.71 AOC3 (0.38) AOC3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0773218-A1 N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis MITSUBISHI CHEMICAL CORPORATION (JP) 1997-05-14 — — EP disclosed
Send feedback